Navigation und Service

Zielgruppeneinstiege

Hinweis zur Verwendung von Cookies

Mit dem Klick auf "Erlauben" erklären Sie sich damit einverstanden, dass wir Ihren Aufenthalt auf der Seite anonymisiert aufzeichnen. Die Auswertungen enthalten keine personenbezogenen Daten und werden ausschließlich zur Analyse, Pflege und Verbesserung unseres Internetauftritts eingesetzt. Weitere Informationen zum Datenschutz erhalten Sie über den folgenden Link: Datenschutz

OK

Abstract zur Publikation: The negative regulator of Borna Disease Virus polymerase is a non-structural protein

Schwardt M, Mayer D, Frank R, Schneider U, Eickmann M, Planz O, Wolff T, Schwemmle M (2005): The negative regulator of Borna Disease Virus polymerase is a non-structural protein
J. Gen. Virol. 86 (11): 3163-3169.

The X protein of Borna Disease Virus (BDV) negatively regulates the viral polymerase activity. With a BDV mini replicon system, 30 % inhibition of polymerase activity is observed at an X to phosphoprotein (P) plasmid ratio of 1 to 6 and 100% inhibition at a ratio of 1:1. We therefore hypothesized that i) the X to P protein ratio in infected cells is not significantly higher than 1 to 6 to prevent complete inhibition of polymerase activity, and ii) that X is not efficiently incorporated into viral particles to allow efficient replication early in infection. To test these assumptions, we generated a monoclonal antibody directed against BDV-X. Immunofluorescence analysis revealed co-localiziation of X with the nucleoprotein (N) and P in the nucleus as well as in the cytoplasm of BDV-infected cells. Quantification of viral protein levels by Western blot analysis, using purified E. coli-derived X, P and N as protein standards, revealed an X to P to N ratio in BDV-infected cells of approximately 1:6:40. However, only traces of X could be detected in purified BDV virus stock, suggesting that X is excluded from virus particles. These results indicate that X is a non-structural protein. The lack of X in virus particles may facilitate polymerase activity early in infection; however, the presence of X in persistently infected cells may result in partial inhibition of the polymerase and thus contribute to viral persistence.

Zusatzinformationen

Gesundheits­monitoring

In­fek­ti­ons­schutz

Forschung

Kom­mis­sio­nen

Ser­vice

Das Robert Koch-Institut ist ein Bundesinstitut im Geschäftsbereich des Bundesministeriums für Gesundheit

© Robert Koch-Institut

Alle Rechte vorbehalten, soweit nicht ausdrücklich anders vermerkt.